Treatment
Treatment A clinical trials
We’re tracking 8,310 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT07490262RecruitingPhase 2/Phase 3
Immunotherapy combo for advanced liver cancer as first treatment
This trial tests a new combination of two immunotherapy drugs (IBI310 and sintilimab) as a first treatment for advanced liver cancer that cannot be removed by surgery. It aims to see if this combination is safe and works better than current options.
Hefei, AnhuiAges 18–75 - NCT07496372RecruitingPhase 3
Stem cell injection for advanced heart failure
This trial tests a treatment made from stem cells that are turned into heart muscle cells and injected directly into the heart. It is for people with advanced heart failure who are already on the best available medicines and who are scheduled to have bypass surgery.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT06456359RecruitingPhase 2
Pasireotide maintenance for synovial sarcoma and DSRCT
This trial tests a drug called pasireotide as a maintenance therapy (given after standard treatment to keep cancer from coming back) for people with specific types of sarcoma. It's for patients whose tumors show high levels of certain proteins (SSTR) and who have stable or better disease after standard treatment.
Heidelberg, Baden-WurttembergAges 13–50 - NCT06179524RecruitingPhase 2
CAR-T-19 for CD19-positive B-ALL in children and young adults
This trial tests a new type of immunotherapy called CAR-T-19 for children and young adults up to age 25 whose B-ALL has returned or is not responding to standard treatments. The CAR-T cells are engineered to find and destroy leukemia cells that have the CD19 protein.
TianjinAges Up to 25 years - NCT06085300Recruiting
Bilingual treatment study for children with language delays
This study looks at how bilingual children with language delays respond to treatment in English or Spanish. It aims to find the best way to help them improve their language skills.
Houston, TexasAges 4–6 - NCT05796739Recruiting
Stress testing once or only when needed for high calcium risk
This study compares two approaches to stress testing in people who feel fine but have high coronary artery calcium on a scan. It may help determine whether testing routinely is better than doing it only if symptoms or concerns arise.
SeoulAges 19 years+ - NCT06233838Recruiting
Hemoperfusion study for kidney patients on dialysis
This trial tests a special blood-filtering treatment (hemoperfusion) for people with advanced kidney disease on regular dialysis. It aims to remove harmful substances that standard dialysis may not fully clear.
Fuzhou, FujianAges 18 years+ - NCT06774209Recruiting
Imaging study for pelvic tumors using PET and MRI
This study uses special PET scans to better see and understand pelvic tumors. It may help doctors plan treatment more accurately. You may be able to join if you have a pelvic tumor and can have surgery or a biopsy.
Beijing, Beijing MunicipalityAges 18–70 - NCT06774690Recruiting
Arterial treatments for primary liver cancer
This study is watching how treatments that deliver medicine or tiny beads directly into the liver's blood supply work for people with liver cancer. If you have liver cancer and are getting or have gotten one of these treatments, this study wants to learn from your experience.
BolognaAges 18 years+ - NCT06530732RecruitingPhase 3
Neck drainage surgery for Alzheimer's disease
This study tests a new surgical treatment for Alzheimer's disease. The surgery aims to improve drainage in the neck to help clear waste from the brain. This is a first-of-its-kind pilot study to see if it is safe and might help thinking and memory.
Hangzhou, ZhejiangAges Any age - NCT06772935Recruiting
Acupuncture for nerve pain from breast cancer chemo
This trial tests if electroacupuncture can help with nerve pain or numbness caused by taxane chemotherapy for breast cancer. It may offer relief for ongoing symptoms after treatment.
Xining, QinghaiAges 18–75 - NCT07487597RecruitingEarly Phase 1
Engineered T cell therapy for ALPP-positive advanced solid tumors
This trial tests a new type of immune cell therapy designed to target and attack cancer cells that have a specific marker called ALPP. It is for people with advanced solid tumors who have not responded to or cannot have standard treatments.
Nanjing, JiangsuAges 18–70 - NCT07484217RecruitingPhase 3
Testing solriamfetol for depression with daytime sleepiness
This study tests if the drug solriamfetol can help people with major depression who also feel very tired during the day. It aims to improve both mood and daytime sleepiness.
Tucson, ArizonaAges 18–65 - NCT07483567RecruitingPhase 2
Combination treatment before and after stomach cancer surgery
This trial tests a combination of experimental drugs (IBI343, Sintilimab, and chemotherapy) before and after surgery for a specific type of stomach cancer that is CLDN18.2 positive. The goal is to see if this treatment shrinks the tumor and helps prevent the cancer from coming back.
Beijing, Beijing MunicipalityAges 18–75 - NCT07481955RecruitingPhase 2
A study of chlorhexidine and metronidazole plus FB301 for bacterial vaginosis
This trial tests a pre-treatment with chlorhexidine and/or metronidazole before a new drug called FB301 in women with bacterial vaginosis (BV). It aims to see if this combination is safe and works well.
Berlin, State of BerlinAges 18–45 - NCT07486401Recruiting
Blood eosinophil-guided asthma care in primary care
This trial tests whether using a blood test (eosinophil count) to guide asthma treatment works better than usual care for people with mild to moderate asthma. If you have asthma and are on step 1-3 treatment, this study could help improve your symptom control.
SingaporeAges 21–65 - NCT04724928RecruitingPhase 2
PET-CT scan to guide bladder cancer treatment decisions
This Phase 2 study checks whether an FDG PET-CT scan can help doctors better predict bladder cancer risk and adjust treatment. You may still get standard bladder cancer care, but the study uses the scan results to help decide how aggressive treatment should be.
GhentAges 18 years+ - NCT06774222RecruitingPhase 2
Fruquintinib plus chemo for HER2-negative gastric cancer
This trial tests adding fruquintinib (a targeted drug that blocks blood vessel growth) to chemotherapy after surgery for HER2-negative stomach or gastroesophageal junction cancer. It is for patients whose tumor did not respond well to previous treatment before surgery.
ZhengzhouAges 18–75 - NCT06269198Recruiting
Monitoring complications after cancer surgery
This trial tests a smart monitoring system to watch for complications after major cancer surgery. It may help doctors catch problems early so you can recover better.
Copenhagen, Other (Non US)Ages 18 years+ - NCT07487480Recruiting
Guselkumab for Crohn's after ustekinumab
This study looks at whether guselkumab, a different biologic medicine, can help people with Crohn's disease who have already tried ustekinumab but it didn't work well or caused side effects. It aims to see if switching to guselkumab is safe and effective.
Hangzhou, ZhejiangAges 18–75 - NCT07486791Recruiting
Baduanjin exercise for heart health after heart attack
This study tests whether a gentle exercise called 'Lying-Sitting-Standing' Baduanjin can improve heart and lung function and quality of life in people who have had a heart attack and also have heart failure.
Taiyuan, ShanxiAges Up to 85 years - NCT07482384Recruiting
Support program for young women with early-stage breast cancer
This study tests a mobile health program that provides support and information to young women with early-stage breast cancer who are on hormone therapy. The goal is to help you stay on your treatment and manage side effects.
Boston, MassachusettsAges 18–49 - NCT07481253Recruiting
Psychopathy program for male inmates in Portugal
This study tests a program called PSYCHOPATHY.COMP for male prison inmates in Portugal who have high psychopathic traits or antisocial personality disorder. It aims to see if the program can help improve behavior and reduce future problems.
LisbonAges 19–30 - NCT07481539RecruitingPhase 2
Antibiotic shot for severe infections vs. IV method
This study compares a new way of giving the antibiotic piperacillin/tazobactam: a shot under the skin every few hours instead of through an IV line. It is for hospital patients with severe infections who need this medicine continuously.
Udine, Italia/UDAges 18 years+
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,310 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.